Vivo Opportunity Fund Holdings, L.P. - 30 Sep 2025 SCHEDULE 13G Report for Bright Minds Biosciences Inc. Common Stock, no par value (DRUG)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Bright Minds Biosciences Inc. Common Stock, no par value
Symbol
DRUG
Shares outstanding
7,096,625 shares
Disclosed Ownership
454,184 shares
Ownership
6.4%
Form type
SCHEDULE 13G
Filing time
14 Nov 2025, 18:38:08 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 6.4% 454,184 454,184 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 6.4% 454,184 454,184 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.7% 47,433 47,433 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 0.7% 47,433 47,433 0 /s/ Kevin Dai Kevin Dai/Managing Member